Regulators meeting inconclusive, to further analyse data before approving Covishield, Covaxin
The meeting on Wednesday was the second time the SEC had met specifically to consider the vaccine applications.
Share Via Email
| A+A A-
A medic demonstrates administration of COVAXIN COVID-19 vaccine to a health worker during its trials at the Urban Primary Health Centre in Assam. (Photo | PTI)
Express News Service
NEW DELHI: A meeting called by India’s drug regulator on Wednesday to discuss the applications by Serum Institute of India and Bharat Biotech to approve their Covid-19 vaccines remained inconclusive and a next meeting to further analyse the submissions has been called two days later.